Infectious Disease Diagnostics Testing Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Infectious Disease Diagnostics Testing Market Size Shifted, And What Is the Outlook Through 2034?
The market size for diagnostics testing of infectious diseases has seen rapid expansion recently. It is projected to rise from $38.52 billion in 2024 to $42.56 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historic period include escalating outbreaks of diseases such as SARS, Ebola, and Zika, heightened awareness about the significance of early detection and prevention of infectious diseases among both healthcare professionals and the public, increased government funding for disease surveillance, control, and prevention initiatives, a surge in global travel and trade enabling disease spread, and elevated healthcare expenditure, especially in developing economies.
How Much Will the Infectious Disease Diagnostics Testing Market Be Worth in 2029?
Expectations are high for the infectious disease diagnostics testing market, with forecasts predicting massive expansion over the coming years. It is anticipated to reach a valuation of $62.58 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.1%. This growth throughout the forecast period is largely due to the constant appearance of new pathogens like advanced strains of influenza or COVID-19, the push towards personalized medicine and targeted treatments, an increased demand for quick, point-of-care testing solutions, a growing focus on epidemiological surveillance and early detection systems, as well as intensified research and development efforts to create innovative diagnostic technologies and biomarkers. Key trends that are expected to shape the market during this forecast period include the downsizing and making diagnostic devices portable, the use of multiplex assays capable of identifying several pathogens at once, the incorporation of digital health solutions such as mobile applications and telemedicine platforms, the application of next-generation sequencing (NGS) technologies in infectious disease diagnostics, the progression of biosensor technologies for swift and sensitive detection of infectious agents, and the incorporation of AI and machine learning algorithms into diagnostic platforms.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
Which is the Largest Company in the Infectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
What Are the Main Market Drivers in the Infectious Disease Diagnostics Testing Industry?
The anticipated surge in respiratory infections is predicted to drive the growth of the infectious disease diagnostic testing market. Respiratory infections, which impact the respiratory system including the nose, throat, airways, and lungs, are on the rise due to viral and bacterial spread. Causes include close interaction with infected people, inadequate hygiene habits, congested living environments, and seasonal weather changes. Diagnosing and treating these infections crucially rely on infectious disease diagnostic testing as it accurately detects pathogens such as bacteria and viruses in patient samples. For example, the Canadian Institute for Health Information, a non-profit organization in Canada, reported in February 2024 that hospitalizations due to acute upper respiratory infections saw a 32% rise, increasing from 2,114 cases in 2022 to 2,797 cases in 2023. Consequently, this surge in respiratory infections is fueling the expansion of the infectious disease diagnostic testing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
How Is the Infectious Disease Diagnostics Testing Market Segments Structured?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
What Strategic Trends Are Transforming the Infectious Disease Diagnostics Testing Market?
Leading firms in the infectious disease diagnostic testing market are placing emphasis on the creation of groundbreaking technologies, like molecular diagnostics platforms, in order to maintain their market presence. Molecular diagnostics platforms are complex mechanisms designed for the detection and analysis of nucleic acids (DNA or RNA) from organic samples for diagnostic applications. A good example of this is when Becton Dickinson and Company, a medical technology firm based in the US, introduced the BD COR System in May 2022. This system, a fully automated, high-throughput infectious disease molecular diagnostics platform, integrates and automates the entire molecular laboratory procedure from sample examination to diagnostic outcomes, eliminating the requirement for manual sample classification and allowing lab professionals to focus on higher-level tasks. The system is capable of processing up to 1,700 specimens and producing results in 24 hours, providing high-throughput functionalities and superior genotyping for diseases like HPV and STIs.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831
This Report Delivers Insight On:
1. How big is the infectious disease diagnostics testing market, and how is it changing globally?
2. Who are the major companies in the infectious disease diagnostics testing market, and how are they performing?
3. What are the key opportunities and risks in the infectious disease diagnostics testing market right now?
4. Which products or customer segments are growing the most in the infectious disease diagnostics testing market?
5. What factors are helping or slowing down the growth of the infectious disease diagnostics testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
